CDLX vs ZBH · rev $71.2M vs P/E 23, rev $4.26B
Cardlytics Inc (CDLX) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Cardlytics Inc (CDLX) is a advertising agencies company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported CDLX revenue for 2026-06-30 was $71.2M. Net income was -$19.4M. CDLX currently screens at market cap $95.0M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
CDLX currently screens at market cap $95.0M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the CDLX and ZBH stock pages for the full models.
Not investment advice.